Benzinga | Mar 23, 2021 07:12PM EDT

Benzinga's Biotech Small Cap Conference Schedule For Wednesday, Mar. 24, 2021

* 9:25 a.m. EDT - Lantern Pharma (LTRN) CEO, Panna Sharma

* 9:25 a.m. - AcelRx Pharma (ACRX) CEO, Vincent Angotti

* 9:45 a.m. - Kintara Therapeutics (KTRA) CEO, Saiid Zarrabian

* 9:45 a.m. - Lexaria Bioscience (LEXX) Chair, CEO, Chris Bunka

* 10:05 a.m. - PDS Biotech (PDSB) CEO, Frank Bedu-Addo

* 10:35 a.m. - ADiTx Therapeutics (ADTX) CEO, Amro Albanna

* 10:55 a.m. - Lixte Biotech (LIXT) CEO, John Kovach

* 11:15 a.m. - ProPhase Labs (PRPH) CEO, Ted Karkus

* 11:35 a.m. - Qualigen Therapeutics (QLGN) CEO, Michael Poirier, Chief Strategy Officer, Amy Broidrick

* 11:50 a.m. - Lineage Cell Therapeutics (LCTX) CEO, Brian Culley

* 12:10 p.m. - Hoth Therapeutics (HOTH) CEO, Robb Knie

* 12:15 p.m. - Sorrento Therapeutics (SRNE) Chair, CEO, Henry Ji

* 12:30 p.m. - Daxor (DXR) CEO, Michael Feldschuh

* 12:35 p.m. - Greenwich Life Sciences (GLSI) CEO, Snehal Patel

* 12:55 p.m. - OncoSec Immunotherapies (ONCS) CEO, Daniel O'Connor

* 1:20 p.m. - aTyr Pharma (LIFE) CEO, Sanjay Shukla

* 1:40 p.m. - Adial Pharma (ADIL) CEO, William Stilley

* 1:50 p.m. - Immutep (IMMP) CEO, Marc Voigt

* 2:00 p.m. - Ampio Pharma (AMPE) CEO, Michael Macaluso, COO Holli Cherevka, CFO, Dan Stokley

* 2:20 p.m. - RedHill Biopharma (RDHL) CEO Dror Ben-Asher

* 2:30 p.m. - Advaxis (ADXS) CEO, Kenneth Berlin

Note: This schedule does not include panels or fireside chats. The schedule only includes NYSE- or NASDAQ-listed companies. To see the full agenda, click here.